Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects (Q35951631)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects (English)

1 reference

Europe PubMed Central

11 August 2017

Henry Seth Friedman

3

object named as

Henry S Friedman

1 reference

Europe PubMed Central

11 August 2017

Darell D. Bigner

11

object named as

Darell D Bigner

1 reference

Europe PubMed Central

11 August 2017

10

object named as

Allan H Friedman

1 reference

Europe PubMed Central

11 August 2017

David A Reardon

4

object named as

David A Reardon

1 reference

Europe PubMed Central

11 August 2017

Roger E McLendon

1

object named as

Roger E McLendon

1 reference

Europe PubMed Central

11 August 2017

James H. Herndon

7

object named as

James E Herndon

1 reference

Europe PubMed Central

11 August 2017

Michael R Zalutsky

12

object named as

Michael R Zalutsky

1 reference

Europe PubMed Central

11 August 2017

2

object named as

Gamal Akabani

1 reference

Europe PubMed Central

11 August 2017

6

object named as

Ilkcan Cokgor

1 reference

Europe PubMed Central

11 August 2017

Carol J Wikstrand

8

object named as

Carol Wikstrand

1 reference

Europe PubMed Central

11 August 2017

author name string

Linda Cleveland

5

1 reference

Europe PubMed Central

11 August 2017

Susan T Boulton

9

1 reference

Europe PubMed Central

11 August 2017

publication date

30 March 2007

1 reference

Europe PubMed Central

11 August 2017

Nuclear Medicine and Biology

1 reference

Europe PubMed Central

11 August 2017

34

1 reference

Europe PubMed Central

11 August 2017

4

1 reference

Europe PubMed Central

11 August 2017

405-413

1 reference

Europe PubMed Central

11 August 2017

Current status of therapy of solid tumors: brain tumor therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

2 October 2017

Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

2 October 2017

Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

2 October 2017

Interstitial brachytherapy of malignant gliomas: the Memorial Sloan-Kettering Cancer Center experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

2 October 2017

Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

2 October 2017

The morphologic effects of radiation administered therapeutically for intracranial gliomas.A Postmortem study of 25 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

2 October 2017

The central nervous system in childhood leukemia.III. mineralizing microangiopathy and dystrophic calcification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

2 October 2017

Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

27 July 2018

Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

27 July 2018

The Role of Radiosurgery in the Treatment of Malignant Brain Tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

27 July 2018

Macrophage markers in diagnostic neuropathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

27 July 2018

Treatment of intracranial human glioblastoma by direct intratumoral administration of 131I-labelled anti-tenascin monoclonal antibody BC-2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

27 July 2018

Tenascin expression in human glioma cell lines and normal tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

27 July 2018

Preliminary results of interstitial 192Ir brachytherapy for malignant gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

27 July 2018

Loco-regional radioimmunotherapy of high-grade malignant gliomas using specific monoclonal antibodies labeled with 90Y: a phase I study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

24 September 2018

Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

24 September 2018

Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

24 September 2018

The treatment of patients with recurrent malignant gliomas with intratumoral radioimmunoconjugates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

24 September 2018

Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

24 September 2018

Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

24 September 2018

The risk of cerebral radionecrosis in relation to dose, time and fractionation. A follow-up study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

24 September 2018

Immunochemical and biochemical characterization of a glioma-associated extracellular matrix glycoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

24 September 2018

Brain damage from 125I brachytherapy evaluated by MR imaging, a blood-brain barrier tracer, and light and electron microscopy in a rat model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1952684

24 September 2018

Soft-tissue reactions following irradiation of primary brain and pituitary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17499730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental MR study of cerebral radiation injury: quantitative T2 changes over time and histopathologic correlation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17499730

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.NUCMEDBIO.2007.01.009

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35951631&oldid=1747715381"